Advancements in Circulating Tumor Cell Detection for Early Cancer Diagnosis: An Integration of Machine Learning Algorithms with Microfluidic Technologies
Biosensors · 2025
DOI: 10.3390/bios15040220 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biosensors, 2025. Verfasst von Ling An und 2 weiteren Autor:innen. Beteiligte Einrichtung: School of Engineering, Dali University, Dali 671003, China. Hauptthemen laut MEDLINE: Neoplastic Cells, Circulating, Machine Learning, Early Detection of Cancer, Microfluidic Analytical Techniques. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 112 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Circulating tumor cells (CTCs) are vital indicators of metastasis and provide a non-invasive method for early cancer diagnosis, prognosis, and therapeutic monitoring. However, their low prevalence and heterogeneity in the bloodstream pose significant challenges for detection. Microfluidic systems, or “lab-on-a-chip” devices, have emerged as a revolutionary tool in liquid biopsy, enabling efficient isolation and analysis of CTCs. These systems offer advantages such as reduced sample volume, enhanced sensitivity, and the ability to integrate multiple processes into a single platform. Several microfluidic techniques, including size-based filtration, dielectrophoresis, and immunoaffinity capture, have been developed to enhance CTC detection. The integration of machine learning (ML) with microfluidic systems has further improved the specificity and accuracy of CTC detection, significantly advancing the speed and efficiency of early cancer diagnosis. ML models have enabled more precise analysis of CTCs by automating detection processes and enhancing the ability to identify rare and heterogeneous cell populations. These advancements have already demonstrated their potential in improving diagnostic accuracy and enabling more personalized treatment approaches. In this review, we highlight the latest progress in the integration of microfluidic technologies and ML algorithms, emphasizing how their combination has changed early cancer diagnosis and contributed to significant advancements in this field.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Engineering, Dali University, Dali 671003, China.
- Precision Medicine Translational Research Center, West China Hospital, Sichuan University, Chengdu 610041, China.
- Department of Bioengineering, Lehigh University, Bethlehem, PA 18015, USA.
Zitieren
APA
An, L., Liu, Y., & Liu, Y. (2025). Advancements in Circulating Tumor Cell Detection for Early Cancer Diagnosis: An Integration of Machine Learning Algorithms with Microfluidic Technologies. Biosensors. https://doi.org/10.3390/bios15040220
Vancouver
An L, Liu Y, Liu Y. Advancements in Circulating Tumor Cell Detection for Early Cancer Diagnosis: An Integration of Machine Learning Algorithms with Microfluidic Technologies. Biosensors. 2025. doi:10.3390/bios15040220
BibTeX
@article{An2025,
author = {An, Ling and Liu, Yi and Liu, Yaling},
title = {Advancements in Circulating Tumor Cell Detection for Early Cancer Diagnosis: An Integration of Machine Learning Algorithms with Microfluidic Technologies},
journal = {Biosensors},
year = {2025},
doi = {10.3390/bios15040220}
}
EUVIMED